vs

Side-by-side financial comparison of CENTERSPACE (CSR) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $66.6M, roughly 1.2× CENTERSPACE). CENTERSPACE runs the higher net margin — -27.7% vs -38.1%, a 10.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 0.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 1.6%).

Centerspace is a real estate investment company specializing in the ownership, operation, and development of high-quality multifamily residential properties. Its core operating markets cover the U.S. Midwest and Mountain West regions, serving diverse renter segments with both affordable and premium housing options, while focusing on tenant experience and long-term asset value growth.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CSR vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.2× larger
PRCT
$83.1M
$66.6M
CSR
Growing faster (revenue YoY)
PRCT
PRCT
+19.9% gap
PRCT
20.2%
0.3%
CSR
Higher net margin
CSR
CSR
10.4% more per $
CSR
-27.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
1.6%
CSR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CSR
CSR
PRCT
PRCT
Revenue
$66.6M
$83.1M
Net Profit
$-18.4M
$-31.6M
Gross Margin
96.5%
64.9%
Operating Margin
-15.9%
-4.1%
Net Margin
-27.7%
-38.1%
Revenue YoY
0.3%
20.2%
Net Profit YoY
-262.9%
-27.9%
EPS (diluted)
$-1.08
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSR
CSR
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$66.6M
$76.4M
Q3 25
$71.4M
$83.3M
Q2 25
$68.5M
$79.2M
Q1 25
$67.1M
$69.2M
Q4 24
$66.4M
$68.2M
Q3 24
$65.0M
$58.4M
Q2 24
$65.0M
$53.4M
Net Profit
CSR
CSR
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-18.4M
$-29.8M
Q3 25
$53.8M
$-21.4M
Q2 25
$-14.5M
$-19.6M
Q1 25
$-3.7M
$-24.7M
Q4 24
$-5.1M
$-18.9M
Q3 24
$-1.0M
$-21.0M
Q2 24
$-1.3M
$-25.6M
Gross Margin
CSR
CSR
PRCT
PRCT
Q1 26
64.9%
Q4 25
96.5%
60.6%
Q3 25
96.5%
64.8%
Q2 25
96.5%
65.4%
Q1 25
96.4%
63.9%
Q4 24
96.5%
64.0%
Q3 24
96.6%
63.2%
Q2 24
96.6%
59.0%
Operating Margin
CSR
CSR
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-15.9%
-40.6%
Q3 25
-27.8%
Q2 25
-9.9%
-28.0%
Q1 25
7.1%
-39.7%
Q4 24
4.3%
-28.9%
Q3 24
9.8%
-38.4%
Q2 24
11.1%
-50.3%
Net Margin
CSR
CSR
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-27.7%
-39.1%
Q3 25
75.3%
-25.7%
Q2 25
-21.2%
-24.7%
Q1 25
-5.6%
-35.8%
Q4 24
-7.6%
-27.6%
Q3 24
-1.6%
-35.9%
Q2 24
-2.0%
-48.0%
EPS (diluted)
CSR
CSR
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-1.08
$-0.54
Q3 25
$3.19
$-0.38
Q2 25
$-0.87
$-0.35
Q1 25
$-0.22
$-0.45
Q4 24
$-0.31
$-0.34
Q3 24
$-0.40
$-0.40
Q2 24
$-0.19
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSR
CSR
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$12.8M
$245.6M
Total DebtLower is stronger
$1.0B
$51.7M
Stockholders' EquityBook value
$719.2M
$347.7M
Total Assets
$1.9B
$487.1M
Debt / EquityLower = less leverage
1.42×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSR
CSR
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$12.8M
$286.5M
Q3 25
$12.9M
$294.3M
Q2 25
$12.4M
$302.7M
Q1 25
$11.9M
$316.2M
Q4 24
$12.0M
$333.7M
Q3 24
$14.5M
$196.8M
Q2 24
$14.3M
$214.1M
Total Debt
CSR
CSR
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$1.0B
$51.6M
Q3 25
$1.1B
$51.6M
Q2 25
$1.1B
$51.5M
Q1 25
$955.5M
$51.5M
Q4 24
$955.4M
$51.5M
Q3 24
$921.3M
$51.4M
Q2 24
$931.7M
$51.4M
Stockholders' Equity
CSR
CSR
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$719.2M
$365.9M
Q3 25
$748.6M
$380.3M
Q2 25
$710.1M
$385.8M
Q1 25
$636.8M
$389.2M
Q4 24
$752.0M
$402.2M
Q3 24
$672.5M
$241.2M
Q2 24
$680.7M
$251.8M
Total Assets
CSR
CSR
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.9B
$508.1M
Q3 25
$2.1B
$511.5M
Q2 25
$2.0B
$513.1M
Q1 25
$1.9B
$519.4M
Q4 24
$1.9B
$534.0M
Q3 24
$1.9B
$374.1M
Q2 24
$1.9B
$374.4M
Debt / Equity
CSR
CSR
PRCT
PRCT
Q1 26
0.15×
Q4 25
1.42×
0.14×
Q3 25
1.53×
0.14×
Q2 25
1.57×
0.13×
Q1 25
1.50×
0.13×
Q4 24
1.27×
0.13×
Q3 24
1.37×
0.21×
Q2 24
1.37×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSR
CSR
PRCT
PRCT
Operating Cash FlowLast quarter
$98.5M
Free Cash FlowOCF − Capex
$64.3M
FCF MarginFCF / Revenue
96.5%
Capex IntensityCapex / Revenue
51.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$125.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSR
CSR
PRCT
PRCT
Q1 26
Q4 25
$98.5M
$-10.3M
Q3 25
$35.1M
$-6.6M
Q2 25
$25.3M
$-15.0M
Q1 25
$25.4M
$-17.0M
Q4 24
$98.2M
$-32.4M
Q3 24
$32.3M
$-18.8M
Q2 24
$22.9M
$-15.7M
Free Cash Flow
CSR
CSR
PRCT
PRCT
Q1 26
Q4 25
$64.3M
$-12.2M
Q3 25
$25.7M
$-9.5M
Q2 25
$15.5M
$-17.8M
Q1 25
$20.4M
$-18.8M
Q4 24
$41.6M
$-33.6M
Q3 24
$20.5M
$-19.0M
Q2 24
$9.1M
$-16.8M
FCF Margin
CSR
CSR
PRCT
PRCT
Q1 26
Q4 25
96.5%
-15.9%
Q3 25
36.0%
-11.4%
Q2 25
22.7%
-22.5%
Q1 25
30.4%
-27.2%
Q4 24
62.6%
-49.2%
Q3 24
31.5%
-32.6%
Q2 24
14.0%
-31.4%
Capex Intensity
CSR
CSR
PRCT
PRCT
Q1 26
Q4 25
51.3%
2.4%
Q3 25
13.1%
3.4%
Q2 25
14.2%
3.5%
Q1 25
7.5%
2.7%
Q4 24
85.3%
1.7%
Q3 24
18.2%
0.4%
Q2 24
21.2%
2.0%
Cash Conversion
CSR
CSR
PRCT
PRCT
Q1 26
Q4 25
Q3 25
0.65×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSR
CSR

Multi Family Residential$57.3M86%
Other$8.1M12%
Other Property Revenue$1.2M2%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons